Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
10.04
+1.58 (18.68%)
At close: Oct 10, 2025, 4:00 PM EDT
9.82
-0.22 (-2.19%)
After-hours: Oct 10, 2025, 7:59 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
Novel Small Molecule Precision Medicines
75.62M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
75.62M